4//SEC Filing
VERTEX PHARMACEUTICALS INC / MA 4
Accession 0001209191-12-046401
$VRTXCIK 0000875320operating
Filed
Sep 20, 8:00 PM ET
Accepted
Sep 21, 4:25 PM ET
Size
13.2 KB
Accession
0001209191-12-046401
Insider Transaction Report
Form 4
Kelly Lisa
SVP, Human Resources
Transactions
- Exercise/Conversion
Common Stock
2012-09-19$33.00/sh+3,093$102,069→ 21,296 total - Exercise/Conversion
Common Stock
2012-09-19$32.16/sh+954$30,681→ 18,203 total - Sale
Common Stock
2012-09-19$57.61/sh−4,047$233,148→ 17,249 total - Exercise/Conversion
Employee Stock Option (right to buy)
2012-09-19−954→ 0 totalExercise: $32.16Exp: 2018-07-23→ Common Stock (954 underlying) - Exercise/Conversion
Employee Stock Option (right to buy)
2012-09-19−3,093→ 56,907 totalExercise: $33.00Exp: 2019-10-21→ Common Stock (3,093 underlying)
Holdings
- 1,957(indirect: By 401(k))
Common Stock
Footnotes (4)
- [F1]Transaction made pursuant to Ms. Kelly-Croswell's company approved trading plan under Rule 10b5-1.
- [F2]Open market sales reported on this line occurred at a weighted average price of $57.61 (range $57.05 to $57.94).
- [F3]Ms. Kelly-Croswell undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
- [F4]Fully vested.
Documents
Issuer
VERTEX PHARMACEUTICALS INC / MA
CIK 0000875320
Entity typeoperating
IncorporatedMA
Related Parties
1- filerCIK 0000875320
Filing Metadata
- Form type
- 4
- Filed
- Sep 20, 8:00 PM ET
- Accepted
- Sep 21, 4:25 PM ET
- Size
- 13.2 KB